A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2006
11/15/2006	CN1284569C Chinese herb lotion for treating onychomycosis and preparation process thereof
11/15/2006	CN1284553C Application of five-finger fig in preparing adjuvant for treating hepatitis and health foods
11/15/2006	CN1284540C Azithromycin enteric casing preparation and its preparing process
11/15/2006	CN1284534C Aromatic turmeric oil extracts and its preparing process and medicinal composition containing the same
11/15/2006	CN1284526C Method for preparing powdered injection of 'Shuanghuanglian' formulation
11/15/2006	CN1284524C Application of solid liposome nanoparticle for preparing pharmaceutical used for ion leading-in trandermal therapy
11/15/2006	CN1284522C Dextrose and insulin fluid formulation for intravenous infusion
11/14/2006	US7135587 Such as 3-biphenyl-4-yl-3-(2-(3-(pyridin-2-ylamino)pro-poxycarbonylamino) -ethanoylamino)propionic acid; thromboses, cardiac infarction, coronary heart disease, arteriosclerosis, inflammation, tumors. osteoporosis, infections, restenosis
11/14/2006	US7135584 Herpes, hepatitis, and aids virus; administering phosphatides
11/14/2006	US7135552 Useful as a candidate for a vaccine against ticks, particularly Ornithodoros moubata
11/14/2006	US7135501 Clusianon isomers and use thereof
11/14/2006	US7135482 Aids therapy; viricides
11/14/2006	US7135471 Aryl oximes
11/14/2006	US7135465 Sustained release beadlets containing stavudine
11/14/2006	US7135464 Method of administering decitabine
11/14/2006	US7135452 Recombinant SP-A for the treatment or prevention of pulmonary infection and inflammation
11/14/2006	US7135286 Pharmaceutical and diagnostic business systems and methods
11/14/2006	US7135280 Assay to determine efficacy of treatment for mycobacterial infection
11/14/2006	US7135279 4-alpha glucotransferases; enzymes inhibitors; enantimorphs; adrenergic blocking agents; proteases; superoxide dismutases; carbonic anhydrases
11/14/2006	US7135195 Colorless antimicrobioal aqueous suspension of colloidal silver particles having an interior of elemental silver and a surface of silver oxide of given particle diameters; antiseptic and surface disinfectant and for treatment of viral, fungal, and bacterial infections
11/14/2006	US7135191 Suppository based vaccine delivery system for immunizing against urogenital and anorectally transmitted infectious disease in humans and animals
11/14/2006	US7135185 Conserved motif of hepatitis C virus E2/NS1 region
11/14/2006	US7135182 Administration of substrates for transglutaminases or antibodies against such substrates; identification, prevention or treatment of microbial infection of mammalian hosts such as immunocompromised or immunosuppressed humans
11/14/2006	US7135175 Compositions and methods for eliciting an immune response to gram-negative bacterial infections
11/14/2006	CA2342271C Gem substituted hydroxamic acids
11/14/2006	CA2171836C Crystalline anhydrous mycophenolate mofetil and intravenous formulation thereof
11/09/2006	WO2006119060A1 Enzymatic production of peracids using perhydrolytic enzymes
11/09/2006	WO2006118948A2 Therapeutic compositions
11/09/2006	WO2006118605A2 8a, 9-dihydro-4a-h-isothiazolo[5,4-b] quinoline-3, 4-diones and related compounds as anti-infective agents
11/09/2006	WO2006118459A1 Antiviral peptides
11/09/2006	WO2006118351A1 Mono-lysine salts of azole compounds
11/09/2006	WO2006118307A1 Therapeutic agent for pain
11/09/2006	WO2006118256A1 2-aminoquinazoline derivatives
11/09/2006	WO2006118131A1 Peptide having anti-anxiety effect and method for screening thereof
11/09/2006	WO2006117670A1 2-amido-6-amino-8-oxopurine derivatives as toll-like receptor modulators for the treatment of cancer and viral infections, such as hepatitis c
11/09/2006	WO2006117653A1 Azole-based phosphodiesterase inhibitors
11/09/2006	WO2006117586A1 Antibody or a fragment thereof, having neutralizing activity against hiv but not against il2
11/09/2006	WO2006117584A1 Antibody or a fragment thereof, having neutralizing activity against hiv
11/09/2006	WO2006117573A1 Combination therapy
11/09/2006	WO2006117461A2 Alkyl-, alkenyl- et alkynyl carbamate derivatives, the preparation and therapeutic use thereof
11/09/2006	WO2006117399A1 Phthalocyanine derivatives, process for their preparation, pharmaceutical compositions containing them, and their use
11/09/2006	WO2006117306A1 Heterocyclic antiviral compounds
11/09/2006	WO2006117217A2 Novel use of spiegelmers
11/09/2006	WO2006117075A1 Use of indolin-phenylsulfonamide derivatives
11/09/2006	WO2006117019A1 Preparation and procedure for the treatment of udders
11/09/2006	WO2006116804A1 Processed hyoscyamus seed agent for the treatment of tissue disruption
11/09/2006	WO2006084141A8 Suspension formulation of interferon
11/09/2006	WO2006079015A3 Quorum sensing modulators
11/09/2006	WO2006048336B1 Aryl pyrimidyl compounds, pharmaceutical compositions comprising them, their use as antimicrobial agents
11/09/2006	US20060252930 Fki-1366 substances and process for producing the same
11/09/2006	US20060252915 Inhibit the growth of microorganisms in environments with physiological salt concentrations and at the same time have as low as possible a hemolytic activity
11/09/2006	US20060252839 Cyclopenteneones for antiischemic agents, antiinflammatory agents and aging resistance
11/09/2006	US20060252814 Formulation comprising a betablocker and optionally a cholestrol-lowering agent
11/09/2006	US20060252810 e.g. 5-(4-Fluorophenyl)-4-(4-pyridinyl)imidazole-2-thio-3-propyl-N-phthalimide; immunomodulating and cytokine-release-inhibiting action; antiinflammatory agent
11/09/2006	US20060252799 Benzo (F) insoindol derivatives and their use as EP4 receptor ligands
11/09/2006	US20060252795 Chemokine receptor binding heterocyclic compounds
11/09/2006	US20060252792 Immunology for viral diseases and biosynthesis of cytokines of anticancer drugs for tumors
11/09/2006	US20060252789 Amorphous moxifloxacin hydrochloride
11/09/2006	US20060252781 Fused heterocycles as inhibitors of glutamate racemase(muri)
11/09/2006	US20060252772 Novel crystalline forms of gatifloxacin and processes for preparation
11/09/2006	US20060252771 Novel crystalline forms of gatifloxacin and processes for preparation
11/09/2006	US20060252770 Novel crystalline forms of gatifloxacin and processes for preparation
11/09/2006	US20060252764 HIV inhibiting pyrimidines derivatives
11/09/2006	US20060252716 Method for reversing the immunosuppressive effects of the melanoma inhibitory activity "mia"
11/09/2006	US20060252709 Novel semisynthetic macrolide antibiotics of the azalide series
11/09/2006	US20060252691 Topical, oral, intravenous, intraperitoneal, intramuscular, transdermal, nasal, or iontophoretic administration of a RNAIII inhibiting heptapeptide of the sequence Tyr-X2-Pro-X1-Thr-Asn-Phe where X1 is Cys, Trp or Ile, and X2 is Lys or Ser; antibiotic resistance
11/09/2006	US20060252690 Factor VII or VIIa - Like Molecules
11/09/2006	US20060252689 Blood coagulation factor; nucleotide sequence encodes polypeptide; amino acid sequence differs in 1-15 amino acid residues and comprises an introduced in vivo N-glycosylation site; substitution V253N; coagulation related disorders
11/09/2006	US20060252127 Blood coagulation factor; nucleotide sequence encodes polypeptide; amino acid sequence differs in 1-15 amino acid residues and comprises an introduced in vivo N-glycosylation site; substitution V253N; coagulation related disorders
11/09/2006	US20060251675 Mutant cholera holotoxin as an adjuvant and an antigen carrier protein
11/09/2006	US20060251671 Haemophilus influenza outer membrane protein and use thereof in vaccination
11/09/2006	US20060251651 Antagonist and agonist which bind to a strong binding site of chemokine receptor
11/09/2006	US20060251638 Cytoprotection through the use of hif hydroxylase inhibitors
11/09/2006	US20060251635 Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them
11/09/2006	US20060251615 Therapeutic agent for preventing and/or treating sepsis
11/09/2006	US20060251588 Delivery of erectile dysfunction drugs through an inhalation route
11/09/2006	US20060251587 Delivery of analgesics through an inhalation route
11/09/2006	DE10340276B4 Körperpflegemittel mit Silber und Zink Body care products with silver and zinc
11/09/2006	CA2821389A1 Novel method for preventing or treating m tuberculosis infection
11/09/2006	CA2607780A1 Purine derivatives
11/09/2006	CA2607572A1 Phthalocyanine derivatives, process for their preparation, pharmaceutical compositions containing them, and their use
11/09/2006	CA2607185A1 Intracellular active agents
11/09/2006	CA2607089A1 Heterocyclic antiviral compounds
11/09/2006	CA2606386A1 Therapeutic compositions
11/09/2006	CA2606162A1 Peptide having antianxiety activity and screening method therefor
11/09/2006	CA2587485A1 8a, 9-dihydro-4a-h-isothiazolo[5,4-b] quinoline-3, 4-diones and related compounds as anti-infective agents
11/08/2006	EP1719779A2 Antibodies against Matin
11/08/2006	EP1719775A1 Camptothecins with a modified lactone ring
11/08/2006	EP1719773A1 Fused heterotetracyclic compounds and use tehreof as hcv polymerase inhibitor
11/08/2006	EP1719770A2 Quinoline derivatives as antibacterials
11/08/2006	EP1719767A1 Synthesis and antiprotozoal activity of dicationic 3,5-diphenylisoxazoles
11/08/2006	EP1719757A1 Bicyclo derivative
11/08/2006	EP1719520A1 Antigen epitopes of the regulatory protein of virulence factor in staphylococcus aureus and their mimotopes and use
11/08/2006	EP1719515A2 Glycyrrhizin or derivatives thereof for treating or preventing togavirus infections
11/08/2006	EP1719511A2 N-[4-(4-amino-2-ethyl-1H-imidazo[4,5-c]quinolin-1-yl)butyl]methanesulfonamide, a pharmaceutical composition comprising the same and use thereof
11/08/2006	EP1718616A2 Isoquinoline derivatives
11/08/2006	EP1718315A1 High dose, short interval use of sulfated polysaccharides for the treatment of infections
11/08/2006	EP1669379A4 3,5-dimethyl-1-adamantyl-ammonium polymeric salts and the use thereof in the form of antiviral agents
11/08/2006	EP1497322A4 Treatment of infections and other disorders
11/08/2006	EP1494749B1 Process for preparation of pharmaceutical composition containing antiretroviral protease inhibitor with improved bioavailability

1 ... 849 850 851 852 853 854 855 856 857 858 859 860 861 862 863 864 865 866 867 868 869 ... 1798